The siRNA lipoplex delivered siRNA against CD47 and PD-L1 across the BBB into GBM in mice, resulting in the synergistic activation of a T-cell-dependent antitumor immune response in an orthotopic GBM model. The gene discussed is CD47; the disease is glioblastoma.